How much is Protara Therapeutics worth in 2026?

Protara Therapeutics has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Protara Therapeutics raised?

Protara Therapeutics has raised N/A in total funding across 1 funding rounds.

Protara Therapeutics

Drug Discovery

Protara Therapeutics valuation and funding history | Last updated: April 1, 2024 | 1 funding rounds

Current Valuation

N/A

As of April 1, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$45.0M

Last Funding

Apr 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
April 1, 2024	PIPE	$45.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Protara Therapeutics is currently valued at N/A as of April 1, 2024.

Track Protara Therapeutics Valuation Updates

Get notified when Protara Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Protara Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Protara Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Protara Therapeutics Worth in 2026?

Protara Therapeutics is a leading private company in the Drug Discovery sector. Track Protara Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Protara Therapeutics Valuation is Determined

Private company valuations like Protara Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.